NEXGEL, INC. Logo

NEXGEL, INC.

Develops and manufactures advanced hydrogels for healthcare, OTC, and consumer applications.

NXGL | US

Overview

Corporate Details

ISIN(s):
US65344E1073
LEI:
Country:
United States of America
Address:
2150 CABOT BLVD WEST,, 19047 LANGHORNE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NEXGEL, Inc. is a technology company that develops and manufactures advanced, high-water-content hydrogels. Utilizing an electron-beam cross-linking process, the company produces ultra-gentle hydrogel products for healthcare, over-the-counter (OTC), and consumer applications. Its versatile platform is used for wound care, transdermal delivery of active ingredients, beauty and cosmetic treatments, and foot care. Operating from an FDA-registered and ISO-certified cGMP manufacturing facility, NEXGEL offers a range of proprietary formulations, including biodegradable options, and provides custom development services for business partners to deliver their unique ingredients via a hydrogel system.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NEXGEL, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NEXGEL, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NEXGEL, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland
PPGN
PolyPid Ltd. Logo
Develops localized, prolonged-release drug therapies for surgery, oncology & metabolic diseases.
United States of America
PYPD
Praxis Precision Medicines, Inc. Logo
Developing therapies for CNS disorders using insights from genetic epilepsies.
United States of America
PRAX
PRECIGEN, INC. Logo
Develops gene and cell therapies for difficult-to-treat diseases using precision technology.
United States of America
PGEN
Precipio, Inc. Logo
Provides blood cancer diagnostic services & products to improve accuracy for physicians & labs.
United States of America
PRPO
PRECISION BIOSCIENCES INC Logo
A clinical-stage company using ARCUS gene editing to treat cancer and rare genetic diseases.
United States of America
DTIL
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea
335810
Prelude Therapeutics Inc Logo
Clinical-stage oncology company developing novel protein degraders and ADCs for cancer.
United States of America
PRLD
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea
334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore
950210

Talk to a Data Expert

Have a question? We'll get back to you promptly.